TGFB1 and cancer: However, since TGF-β is a pleiotropic cytokine involved in cell proliferation and differentiation, immune regulation, cancer surveillance and wound healing, clinical trials were terminated due to toxicity in patients receiving antibodies or small molecules directly against TGF-β (Henderson et al., 2020).